Live Breaking News & Updates on Sequana Holding

Stay updated with breaking news from Sequana holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sequana Medical NV: Sequana Medical announces positive results from CHIHUAHUA, Phase 1 clinical trial of second-generation DSR product for congestive heart failure

PRESS RELEASE Phase 1 clinical trial (CHIHUAHUA) demonstrates that single dose of second-generation DSR product (DSR 2.0) is safe and well-tolerated, and indicates a compelling dosing profileOn ....

United States , Hong Kong , United Kingdom , Dennis Riedl , Jonathan Edwards , Nick Bastin , Strategic Communications , Good Laboratory Practices , Company Or Sequanamedical , Euronext Brussels , Sequana Medical , Chief Medical Officer , North American , Pre Market Approval , Investigational New , Good Laboratory , Safety Monitoring ,

Sequana Medical - CHIHUAHUA results clear path to MOJAVE

Sequana Medical reported positive results from the CHIHUAHUA Phase I study of its second-generation DSR (direct sodium removal) product, DSR 2.0. This clears a key hurdle needed before filing a US Investigational ....

Dennis Riedl , Sequana Medical , New Drug ,

Sequana Medical NV: Sequana Medical announces results of Extraordinary General Meeting of Shareholders

PRESS RELEASEREGULATED INFORMATION10 February 2023, 18:00 CET Ghent, Belgium - 10 February 2023 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical") ....

United States , Hong Kong , Douglas Kohrs , Alexandra Taylor Clyde , Jonathan Edwards , Sequana Medicalexpressly , Nick Bastin , Strategic Communications , Company Or Sequanamedical , Euronext Brussels , Sequana Medical , North American , Pre Market Approval , Marcel Torney ,

Sequana Medical NV: Sequana Medical announces 2022 Full Year Results and 2023 Outlook

PRESS RELEASEREGULATED INFORMATION09 February 2023, 07:00 CEST alfapump® - successful primary endpoint read-out of North American pivotal POSEIDON study / PMA1 filing planned for H2 2023DSR® ....

Region Flamande , United States , Hong Kong , Cian Crosbie , Peter Dhondt , Jonathan Edwards , Sequana Medicalexpressly , Doug Kohrs , Nick Bastin , Schwierige Zeiten , Alexandra Clyde , York Heart Association , Good Laboratory Practice , Strategic Communications , Company Notified Body , Company Or Sequanamedical , Medicaid Services , Liver International , North American , Direct Sodium Removal , Euronext Brussels , Chief Executive Officer , Sequana Medical , North America , Rosetta Capital , Pivotal Cohort ,

Sequana Medical NV: Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION09 February 2023, 07:00 am CEST Ghent, Belgium - 09 February 2023 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical") ....

United States , Hong Kong , United Kingdom , Dina Chaya , Jonathan Edwards , Nick Bastin , Schwierige Zeiten , Belgian Companies , Neomed Iv Extension Limited , Neomed Management Jersey Limited , Belgian Financial Services , Neomed Innovationv Limited , Strategic Communications , Rosetta Capital Ltd , Company To Rosetta Capital , Company Or Sequanamedical , Euronext Brussels , Rosetta Capital , Neomed Management , Erik Amble , Claudio Nessi , Belgian Act , Sequana Medical , Belgian Transparency Act , Markets Authority , North American ,